Hudson Canyon Capital Management Moderna, Inc. Transaction History

Hudson Canyon Capital Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Aug 02, 2023	BUY	$135.66 - $197.02 $88,314 - $128,260	651 Added 9.59%	7,441 $1.14 Billion
Q2 2022 Aug 02, 2023	BUY	$117.13 - $176.59 $7,613 - $11,478	65 Added 0.97%	6,790 $970 Million
Q1 2022 Aug 02, 2023	BUY	$126.46 - $235.05 $66,391 - $123,401	525 Added 8.47%	6,725 $1.16 Billion
Q4 2021 Aug 02, 2023	BUY	$225.82 - $368.51 $496,804 - $810,722	2,200 Added 55.0%	6,200 $1.57 Billion
Q3 2021 Aug 02, 2023	BUY	$221.9 - $484.47 $887,600 - $1.94 Million	4,000 New	4,000 $1.54 Billion

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Hudson Canyon Capital Management, based on Form 13F filings with the SEC.

Stay updated on Hudson Canyon Capital Management with notifications on news.